Article History
Accepted: 13 June 2022
First Online: 25 July 2022
Competing interests
: K.R. and The University of Texas MD Anderson Cancer Center have an institutional financial conflict of interest with Takeda Pharmaceutical and Affimed GmbH. K.R. participates on the Scientific Advisory Board for GemoAb, AvengeBio, Virogin Biotech, GSK, Bayer, Navan Technologies and Caribou Biosciences. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.